Financials

  • Market Capitalization 5.42 M
  • Employee 6
  • Founded 2009
  • CEO N/A
  • Website www.kalarx.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2MVT8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.17
Rapporto prezzo/fatturato
—

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4803
CELZ
Creative Medical Technology Holdings, Inc. - Common Stock
0.84 USD0.00%-6.67%-11.58%-75.00%5.54 M USD
4804
AIM
AIM ImmunoTech Inc. Common Stock
0.18 USD0.00%-5.26%-18.18%-93.03%5.48 M USD
4811
LEXX
Lexaria Bioscience Corp. - Common Stock
3.27 USD-1.51%+11.60%-17.84%+263.33%5.40 M USD
4818
PCSA
Processa Pharmaceuticals, Inc. - Common Stock
1.90 USD+25.00%+22.58%-3.55%-14.60%5.31 M USD

Notizie